help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rooman, R. P. A.
Right arrow Articles by van Buul-Offers, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rooman, R. P. A.
Right arrow Articles by van Buul-Offers, S. C.
Endocrinology Vol. 144, No. 6 2553-2558
Copyright © 2003 by The Endocrine Society

Dexamethasone Differentially Inhibits Thyroxine- or Growth Hormone-Induced Body and Organ Growth of Snell Dwarf Mice

Raoul P. A. Rooman, Gilliam Kuijpers, Ria Gresnigt, Ruud Bloemen, Johanna G. Koster and Sylvia C. van Buul-Offers

Department of Pediatric Endocrinology, University Medical Center, 3508 AB Utrecht, The Netherlands

Address all correspondence and requests for reprints to: Raoul Rooman, M.D., Department of Pediatrics, Antwerp University Hospital, Wilrijkstraat 10, B-2650 Edegem, Belgium. E-mail: raoul.rooman{at}uza.be.

Supraphysiological doses of glucocorticoids cause growth retardation in both animals and humans. Many studies have addressed the interaction of glucocorticoids with the GH/IGF system, but little is known about the effect of glucocorticoids on T4-stimulated growth. The Snell dwarf mouse is deficient in GH, thyroid-stimulating hormone, and prolactin and therefore allows the study of the effect of glucocorticoids on the growth induced by GH and T4 without their mutual interaction. Four weeks of treatment with T4 (1 µg/d) or human GH (50 mU/d) equally increased nose-tail length (3.1 ± 0.1 cm and 3.0 ± 0.2 cm, respectively). Dexamethasone (DXM) had much less impact on T4-stimulated growth than on GH-induced growth (T4 + DXM: 2.4 ± 0.1 cm vs. GH+ DXM: 1.4 ± 0.1 cm). Similar data were obtained for body weight gain. T4 and GH had a different effect on the weight of various organs: GH caused a higher increase in liver and lumbar vertebrae weight, and T4 was a better stimulator for kidney (P < 0.05), thymus, and spleen growth. Remarkably, T4-stimulated growth of the organs was less affected by DXM than GH-induced organ growth. GH even potentiated the growth inhibition by DXM in the thymus and tibia. In conclusion, T4-stimulated growth in Snell dwarf mice is less affected by DXM than growth stimulated by GH




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
F. Schaefer, S.-A. Yoon, P. Nouri, T. Tsao, P. Tummala, E. Deng, and R. Rabkin
Growth Hormone-Mediated Janus Associated Kinase-Signal Transducers and Activators of Transcription Signaling in the Growth Hormone-Resistant Potassium-Deficient Rat
J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2299 - 2306.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society